Predictive Modelling of Patient Reported Radiotherapy-Related Toxicity by the Application of Symptom Clustering and Autoregression

Authors

  • A. Lemanska School of Health Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK
  • A. Cox School of Health Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK
  • N. F. Kirkby University of Surrey
  • T. Chen Department of Chemical and Process Engineering, University of Surrey, Guildford GU2 7XH, UK
  • S. Faithfull School of Health Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK

DOI:

https://doi.org/10.6000/1929-6029.2014.03.04.10

Keywords:

Predictive Modeling, Patient Reported Outcome Measures, Autoregression, Radiotherapy-Related Side Effects, Longitudinal Study.

Abstract

Patient reported outcome measures (PROMs) are increasingly being used in research to explore experiences of cancer survivors. Techniques to predict symptoms, with the aim of providing triage care, rely on the ability to analyse trends in symptoms or quality of life and at present are limited. The secondary analysis in this study uses a statistical method involving the application of autoregression (AR) to PROMs in order to predict symptom intensity following radiotherapy, and to explore its feasibility as an analytical tool. The technique is demonstrated using an existing dataset of 94 prostate cancer patients who completed a validated battery of PROMs over time. In addition the relationship between symptoms was investigated and symptom clusters were identified to determine their value in assisting predictive modeling. Three symptom clusters, namely urinary, gastrointestinal and emotional were identified. The study indicates that incorporating symptom clustering into predictive modeling helps to identify the most informative predictor variables. The analysis also showed that the degree of rise of symptom intensity during radiotherapy has the ability to predict later radiotherapy-related symptoms. The method was most successful for the prediction of urinary and gastrointestinal symptoms. Quantitative or qualitative prediction was possible on different symptoms. The application of this technique to predict radiotherapy outcomes could lead to increased use of PROMs within clinical practice. This in turn would contribute to improvements in both patient care after radiotherapy and also strategies to prevent side effects. In order to further evaluate the predictive ability of the approach, the analysis of a larger dataset with a longer follow up was identified as the next step.

Author Biographies

A. Lemanska, School of Health Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK

Health and Medical Sciences

A. Cox, School of Health Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK

Health and Medical Sciences

N. F. Kirkby, University of Surrey

Chemical and Process Engineering

T. Chen, Department of Chemical and Process Engineering, University of Surrey, Guildford GU2 7XH, UK

Chemical and Process Engineering

S. Faithfull, School of Health Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK

Health and Medical Sciences

References

Richards M, Corner J, Maher J. The National Cancer Survivorship Initiative: new and emerging evidence on the ongoing needs of cancer survivors. Br J Cancer 2011; 105(S1): S1-S4. http://dx.doi.org/10.1038/bjc.2011.416 DOI: https://doi.org/10.1038/bjc.2011.416

Maher J, McConnell H. New pathways of care for cancer survivors: adding the numbers. Br J Cancer 2011; 105(S1): S5-S10. http://dx.doi.org/10.1038/bjc.2011.417 DOI: https://doi.org/10.1038/bjc.2011.417

Khan NF, Evans J, Rose PW. A qualitative study of unmet needs and interactions with primary care among cancer survivors. Br J Cancer 2011; 105(S1): S46-S51. http://dx.doi.org/10.1038/bjc.2011.422 DOI: https://doi.org/10.1038/bjc.2011.422

Elliott J, Fallows A, Staetsky L, et al. The health and well-being of cancer survivors in the UK: findings from a population-based survey. Br J Cancer 2011; 105(S1): S11-S20. http://dx.doi.org/10.1038/bjc.2011.418 DOI: https://doi.org/10.1038/bjc.2011.418

Armes J, Crowe M, Colbourne L, et al. Patients' supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol 2009; 27(36): 6172-9. http://dx.doi.org/10.1200/jco.2009.22.5151 DOI: https://doi.org/10.1200/JCO.2009.22.5151

Ream E, Quennell A, Fincham L, et al. Supportive care needs of men living with prostate cancer in England: a survey. Br J Cancer 2008; 98(12): 1903-9. http://dx.doi.org/10.1038/sj.bjc.6604406 DOI: https://doi.org/10.1038/sj.bjc.6604406

Davidson SE, Faithfull S. Late radiotherapy effects: is bowel morbidity adequately documented or patients' needs managed appropriately? Clin Oncol 2006; 18(5): 419-20. http://dx.doi.org/10.1016/j.clon.2006.03.005 DOI: https://doi.org/10.1016/j.clon.2006.03.005

Basch E, Abernethy AP, Mullins CD, et al. Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol 2012; 30(34): 4249-55. http://dx.doi.org/10.1200/JCO.2012.42.5967 DOI: https://doi.org/10.1200/JCO.2012.42.5967

Department of Health, Macmillan Cancer Support and NHS Improvement. National Cancer Survivorship Initiative (NCSI) vision. 2010. Accessed: 10 October 2014, http://webarchive. nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_111477.pdf

Osoba D. Health-related quality of life and cancer clinical trials. Ther Adv Med Oncol 2011; 3(2): 57-71. http://dx.doi.org/10.1177/1758834010395342 DOI: https://doi.org/10.1177/1758834010395342

FDA. Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims. 2009. Accessed: 10 October 2014, http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf

Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health 2005; 8(2): 94-104. DOI: https://doi.org/10.1111/j.1524-4733.2005.04054.x

Frost MH, Reeve BB, Liepa AM, Stauffer JW, Hays RD. What is sufficient evidence for the reliability and validity of patient-reported outcome measures? Value Health 2007; 10(2): S94-S105. http://dx.doi.org/10.1111/j.1524-4733.2007.00272.x DOI: https://doi.org/10.1111/j.1524-4733.2007.00272.x

Two R, Verjee-Lorenz A, Clayson D, et al. A methodology for successfully producing global translations of patient reported outcome measures for use in multiple countries. Value Health 2010; 13(1): 128-31. http://dx.doi.org/10.1111/j.1524-4733.2009.00585.x DOI: https://doi.org/10.1111/j.1524-4733.2009.00585.x

Skerman HM, Yates PM, Battistutta D. Identification of cancer-related symptom clusters: an empirical comparison of exploratory factor analysis methods. J Pain Symptom Manage 2012; 44(1): 10-22. http://dx.doi.org/10.1016/j.jpainsymman.2011.07.009 DOI: https://doi.org/10.1016/j.jpainsymman.2011.07.009

Skerman HM, Yates PM, Battistutta D. Multivariate methods to identify cancer-related symptom clusters. Res Nurs Health 2009; 32(3):345-60. http://dx.doi.org/10.1002/nur.20323 DOI: https://doi.org/10.1002/nur.20323

Miaskowski C, Dodd M, Lee K. Symptom clusters: the new frontier in symptom management research. J Natl Cancer Inst Monogr 2004; 32: 17-21. http://dx.doi.org/10.1093/jncimonographs/lgh023 DOI: https://doi.org/10.1093/jncimonographs/lgh023

Kirkova J, Walsh D. Cancer symptom clusters - a dynamic construct. Support Care Cancer 2007; 15(9): 1011-3. http://dx.doi.org/10.1007/s00520-007-0259-2 DOI: https://doi.org/10.1007/s00520-007-0259-2

Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN. Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manage 2006; 31(1): 85-95. http://dx.doi.org/10.1016/j.jpainsymman.2005.05.015 DOI: https://doi.org/10.1016/j.jpainsymman.2005.05.015

Parker KP, Kimble LP, Dunbar SB, Clark PC. Symptom Interactions as Mechanisms Underlying Symptom Pairs and Clusters. J Nurs Scholarsh 2005; 37(3): 209-15. http://dx.doi.org/10.1111/j.1547-5069.2005.00037.x DOI: https://doi.org/10.1111/j.1547-5069.2005.00037.x

Motl RW, McAuley E. Symptom cluster and quality of life: preliminary evidence in multiple sclerosis. J Neurosci Nurs 2010; 42(4): 212-6. http://dx.doi.org/10.1097/JNN.0b013e3181e26c5f DOI: https://doi.org/10.1097/JNN.0b013e3181e26c5f

Fan G, Filipczak L, Chow E. Symptom clusters in cancer patients: a review of the literature. Curr Oncol 2007; 14(5): 173-9. DOI: https://doi.org/10.3747/co.2007.145

Esther Kim J-E, Dodd MJ, Aouizerat BE, Jahan T, Miaskowski C. A review of the prevalence and impact of multiple symptoms in oncology patients. J Pain Symptom Manage 2009; 37(4): 715-36. http://dx.doi.org/10.1016/j.jpainsymman.2008.04.018 DOI: https://doi.org/10.1016/j.jpainsymman.2008.04.018

Degner LF, Sloan JA. Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer. J Pain Symptom Manage 1995; 10(6): 423-31. http://dx.doi.org/10.1016/0885-3924(95)00056-5 DOI: https://doi.org/10.1016/0885-3924(95)00056-5

Xiao C. The state of science in the study of cancer symptom clusters. Eur J Oncol Nurs 2010; 14(5): 417-34. http://dx.doi.org/10.1016/j.ejon.2010.05.011 DOI: https://doi.org/10.1016/j.ejon.2010.05.011

Quinten C, Maringwa J, Gotay CC, et al. Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. J Natl Cancer Inst 2011; 103(24): 1851-8. http://dx.doi.org/10.1093/jnci/djr485 DOI: https://doi.org/10.1093/jnci/djr485

Osoba D. Health-related quality of life and predicting survival in cancer: not a simple matter. Support Care Cancer 2007; 15(4): 353-5. http://dx.doi.org/10.1007/s00520-006-0187-6 DOI: https://doi.org/10.1007/s00520-006-0187-6

Wedlake LJ, Thomas K, Lalji A, et al. Predicting Late Effects of Pelvic Radiotherapy: Is There a Better Approach? Int J Radiat Oncol Biol Phys 2010; 78(4): 1163-70. http://dx.doi.org/10.1016/j.ijrobp.2009.09.011 DOI: https://doi.org/10.1016/j.ijrobp.2009.09.011

Sarenmalm K, Elisabeth, Öhlén J, Odén A, Gaston-Johansson F. Experience and predictors of symptoms, distress and health-related quality of life over time in postmenopausal women with recurrent breast cancer. Psychooncology 2008; 17(5): 497-505. http://dx.doi.org/10.1002/pon.1258 DOI: https://doi.org/10.1002/pon.1258

Faithfull S, Corner J, Meyer L, Huddart R, Dearnaley D. Evaluation of nurse-led follow up for patients undergoing pelvic radiotherapy. Br J Cancer 2001; 85(12): 1853-64. http://dx.doi.org/10.1054/bjoc.2001.2173 DOI: https://doi.org/10.1054/bjoc.2001.2173

Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85(5): 365-76. http://dx.doi.org/10.1093/jnci/85.5.365 DOI: https://doi.org/10.1093/jnci/85.5.365

Portenoy RK, Thaler HT, Kornblith AB, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 1994; 30(9): 1326-36. http://dx.doi.org/10.1016/0959-8049(94)90182-1 DOI: https://doi.org/10.1016/0959-8049(94)90182-1

Portenoy RK, Thaler HT, Kornblith AB, et al. Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res 1994; 3(3): 183-9. http://dx.doi.org/10.1007/BF00435383 DOI: https://doi.org/10.1007/BF00435383

Faithfull S. 'Just grin and bear it and hope that it will go away’: coping with urinary symptoms from pelvic radiotherapy. Eur J Cancer Care 1995; 4(4): 158-65. http://dx.doi.org/10.1111/j.1365-2354.1995.tb00087.x DOI: https://doi.org/10.1111/j.1365-2354.1995.tb00087.x

Bowling A. Measuring health: a review of quality of life measurement scales. 2nd ed. Milton Keynes: Open University Press 1997.

Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs 2005; 14(7): 798-804. http://dx.doi.org/10.1111/j.1365-2702.2005.01121.x DOI: https://doi.org/10.1111/j.1365-2702.2005.01121.x

Jensen MP. The validity and reliability of pain measures in adults with cancer. J Pain 2003; 4(1): 2-21. http://dx.doi.org/10.1054/jpai.2003.1 DOI: https://doi.org/10.1054/jpai.2003.1

Hjermstad MJ, Fayers PM, Haugen DF, et al. Studies comparing numerical rating scales, verbal rating scales, and visual analogue scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage 2011; 41(6): 1073-93. http://dx.doi.org/10.1016/j.jpainsymman.2010.08.016 DOI: https://doi.org/10.1016/j.jpainsymman.2010.08.016

Molenberghs G. Missing data in clinical studies. 1st ed. Chichester: John Wiley & Sons 2007. DOI: https://doi.org/10.1002/9780471462422.eoct044

Brereton RG. Chemometrics for pattern recognition. 1st ed. Chichester: John Wiley & Sons 2009. DOI: https://doi.org/10.1002/9780470746462

Chatfield C. The analysis of time series. An introduction. 4th ed. New York, NY: Chapman and Hall 1989.

Peng H, Ozaki T, Toyoda Y, et al. RBF-ARX model-based nonlinear system modeling and predictive control with application to a NOx decomposition process. Control Eng Pract 2004; 12(2): 191-203. http://dx.doi.org/10.1016/s0967-0661(03)00050-9 DOI: https://doi.org/10.1016/S0967-0661(03)00050-9

Geladi P, Kowalski BR. Partial least-squares regression: a tutorial. Anal Chim Acta 1986; 185(0): 1-17. http://dx.doi.org/10.1016/0003-2670(86)80028-9 DOI: https://doi.org/10.1016/0003-2670(86)80028-9

Campbell MJ, Machin D. Medical statistics: a commonsense approach. 3rd ed. Chichester: John Wiley & Sons 1999.

Martens HA, Dardenne P. Validation and verification of regression in small data sets. Chemometr Intell Lab Syst 1998; 44(1–2): 99-121. http://dx.doi.org/10.1016/s0169-7439(98)00167-1 DOI: https://doi.org/10.1016/S0169-7439(98)00167-1

Larsen A, Bjørge B, Klementsen B, et al. Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy. Acta Oncol 2007; 46(5): 639-50. http://dx.doi.org/10.1080/02841860601099241 DOI: https://doi.org/10.1080/02841860601099241

Denham JW, Hauer-Jensen M. The radiotherapeutic injury – a complex ‘wound’. Radiother and Oncol 2002; 63(2): 129-45. http://dx.doi.org/10.1016/s0167-8140(02)00060-9 DOI: https://doi.org/10.1016/S0167-8140(02)00060-9

Andreyev HJN, Wotherspoon A, Denham JW, Hauer-Jensen M. Defining pelvic-radiation disease for the survivorship era. Lancet Oncol 2010; 11(4): 310-2. http://dx.doi.org/10.1016/s1470-2045(10)70026-7 DOI: https://doi.org/10.1016/S1470-2045(10)70026-7

Downloads

Published

2014-11-06

How to Cite

Lemanska, A., Cox, A., Kirkby, N. F., Chen, T., & Faithfull, S. (2014). Predictive Modelling of Patient Reported Radiotherapy-Related Toxicity by the Application of Symptom Clustering and Autoregression. International Journal of Statistics in Medical Research, 3(4), 412–422. https://doi.org/10.6000/1929-6029.2014.03.04.10

Issue

Section

General Articles